Lataa...
On improvement in ejection fraction with iron chelation in thalassemia major and the risk of future heart failure
BACKGROUND: Trials of iron chelator regimens have increased the treatment options for cardiac siderosis in beta-thalassemia major (TM) patients. Treatment effects with improved left ventricular (LV) ejection fraction (EF) have been observed in patients without overt heart failure, but it is unclear...
Tallennettuna:
| Päätekijät: | , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2011
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3180261/ https://ncbi.nlm.nih.gov/pubmed/21910880 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1532-429X-13-45 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|